ClinConnect ClinConnect Logo
Search / Trial NCT06782321

Emotional Recovery Post-Stroke

Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Jan 16, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Rehabilitation Studies Stroke Stroke Recovery

ClinConnect Summary

The "Emotional Recovery Post-Stroke" clinical trial is looking to see if adding emotional wellness support to existing therapy programs can help people who have had a stroke feel better emotionally and participate more in daily activities. Participants in this study will take part in telerehabilitation, which means they will receive therapy through video calls from the comfort of their own homes. This study aims to help individuals who have experienced a stroke and are dealing with emotional challenges such as anxiety, sadness, or sleep problems.

To be eligible for this trial, participants should be at least 21 years old, have had a stroke at least 30 days prior, and be able to communicate in English. They should also have some difficulties with emotional wellness related to their stroke, like feeling fearful or losing hope. Participants will need to have a device like a smartphone or tablet and a good internet connection to join the sessions. It’s important to note that people who have significant pain affecting movement or who are unable to follow simple instructions will not be able to participate. Overall, this study could provide valuable insights into how emotional support can enhance recovery after a stroke.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Self-reported stroke-related deficits in emotional wellness such as anxiety, sleep disturbance, dread, fear, loss of hope, sadness.
  • Have experienced ischemic or hemorrhagic stroke at least 30 days prior
  • Stroke-related aphasia and/or upper extremity hemiparesis
  • Aged 21 years or older
  • English as primary language
  • Have corrected vision to be able to read text on a screen
  • Able to participate fully in the study's tele-rehabilitation (Aim 1) and/or virtual group programing (Aim 2) with personally owned device (i.e., phone, tablet, or laptop) and personal Wi-Fi connection or cellular service
  • Cognitive, language, and motor capacity to participate fully in the study's assessment session as per the judgment of the licensed, experienced stroke tele-rehabilitation occupational or speech therapist
  • Exclusion Criteria:
  • Unable to follow 1-2 step instructions given by the study team member during the informed consent procedures.
  • Pain that interferes with ability to participate in the study's upper extremity movement tasks.
  • Have impaired decision making capacity as determined by the U-ARE protocol for assessing capacity to provide informed consent.

About Medical University Of South Carolina

The Medical University of South Carolina (MUSC) is a leading academic health center dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on translational medicine, MUSC leverages its extensive resources and expertise to facilitate groundbreaking studies across various medical disciplines. The institution is committed to fostering collaboration among researchers, healthcare professionals, and patients, ensuring that cutting-edge discoveries translate into effective treatments. As a pioneer in health education and research, MUSC plays a vital role in shaping the future of medicine and enhancing health outcomes in the community and beyond.

Locations

Charleston, South Carolina, United States

Patients applied

0 patients applied

Trial Officials

Michelle Woodbury, PhD

Principal Investigator

Medical University of South Carolina

Lisa McTeague, PhD

Principal Investigator

Medical University of South Carolina

Deena Blackett, PhD

Principal Investigator

University of Central Florida

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported